Cellex Cell Professionals

Cellex is an established, full-service CDMO with over a decade of experience in the advanced therapy medicinal product (ATMP) space. It partners with pharmaceutical companies, biotech firms, and academic institutions to provide end-to-end solutions, including cell collection, process development, GMP manufacturing, and supply chain logistics. The company's significant achievement includes the production of multiple approved CAR-T therapies, positioning it as a trusted and capable partner in the complex cell and gene therapy ecosystem. Its business model is purely service-based, generating revenue from its CDMO and consulting activities.

Integrated GMP CDMO platform for cell and gene therapies, specializing in autologous/allogeneic process development, cell collection logistics, GMP manufacturing, and regulatory consulting.

Cellex competes in the specialized CGT CDMO space against larger global players like Lonza, Catalent, and Thermo Fisher's Patheon, as well as other focused CDMOs like Oxford Biomedica and ElevateBio. Its competitive advantages are its long-standing European focus, specific expertise in autologous cell collection and logistics, and a proven history of manufacturing approved therapies.